Searched for
PHARMA INDUSTRY
Experiments on animals set to become easierThe Centre plans to significantly change the regulations governing animal experimentation. The proposed rules aim to allow institutional et...- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets ended lower on Wednesday as the Sensex fell 429 points and Nifty dropped over 173 points, snapping a two-session rally. Inve...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
- NSE shares wipe off Rs 41,000 crore after listing day pop as stock slips below IPO price. Why are analysts still bullish?NSE shares have slipped below their IPO price after a brief listing-day rally, wiping out nearly Rs 41,000 crore from the exchange’s peak m...
- Centre may seek legal view on licensing of sterile drugsThe government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...
- Industrial alcohol is the GST Council's unfinished federal business: States won the legal fight, but the 18% GST still appliesThe GST Council is set to meet regarding the regulation of industrial alcohol, which has been contested between the government and states. ...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- FIIs, retail investors raise stakes in 10 stocks, shares rally up to 35% in 3 monthsNearly 78 BSE 500 stocks saw both FII and retail ownership rise in June 2026. Ten stocks gained 10%-35% over three months, led by Lenskart ...
- GST 2.0: Council to consider sweeping reforms to unlock tax credit, ease complianceIndia is set to implement significant reforms to the goods and services tax system, which will ease compliance. Changes may include the rel...
- AMFI reshuffle: NSE may get largecap status, SBI Fund Management may become midcap in H1 CY27Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens E...
- Stock Radar: Dr Lal PathLabs stock hits fresh record high in September; will the rally continue in October 2026?Dr Lal PathLabs Ltd has recently experienced a rally but could not maintain its peak price levels. Experts suggest that the stock may targe...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Globalisation 2.0, can it be furrowed home?Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...
- MTAR Tech among 4 stocks showing White Marubozu patternFour Nifty 500 stocks, including MTAR Technologies, Mankind Pharma, CMPDI, and PTC Industries, formed a White Marubozu bullish candlestick ...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
Load More
